However, it is not clear how targeting this axis influences the pathogenesis of COPD (along with overcoming steroid resistance) as it is difficult to target CXCR2 while retaining critical host defense and tissue repair capacity. This evidence concerns the gene CXCR2 and chronic obstructive pulmonary disease.